USE OF FUSION PROTEINS FOR THE PREVENTION OR THE TREATMENT OF PATHOLOGIES RESULTING FROM ISCHEMIA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090118180A1
SERIAL NO

12088725

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a fusion protein including a peptide sequence having membrane transducing properties, and a peptide sequence having cell survival properties, or a nucleic acid coding for the fusion protein, for the manufacture of a medicament intended for the prevention or the treatment of pathologies resulting from ischemia.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
I N S E R M (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE101 RUE DE TOLBIAC F-75654 PARIS CEDEX 13

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Braudeau, Jerome Paris, FR 4 0
Couriaud, Cecile Paris, FR 1 0
Guegan, Christelle Paris, FR 1 0
Onteniente, Brigitte Creteil, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation